{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:14:04Z","timestamp":1777497244517,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CH"],"published-print":{"date-parts":[[2017,1,21]]},"DOI":"10.3233\/ch-168104","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T11:27:33Z","timestamp":1479814053000},"page":"273-278","source":"Crossref","is-referenced-by-count":5,"title":["Antiplatelet therapies in patients with\u00a0an\u00a0indication for anticoagulation"],"prefix":"10.1177","volume":"64","author":[{"given":"Helen","family":"Ullrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"13","key":"10.3233\/CH-168104_ref1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jcin.2016.04.009","article-title":"Time-dependent associations between actionable bleeding, coronary thrombotic events, and mortality following percutaneous coronary intervention: Results from the PARIS registry","volume":"9","author":"Baber","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.3233\/CH-168104_ref2","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.3233\/CH-168104_ref3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ahj.2014.11.005","article-title":"Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: Lessons from HORIZONS-AMI","volume":"169","author":"Brener","year":"2015","journal-title":"American Heart Journal"},{"issue":"6","key":"10.3233\/CH-168104_ref4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000024408.81821.32","article-title":"Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: Results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial","volume":"106","author":"Brouwer","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.3233\/CH-168104_ref5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11239-014-1132-z","article-title":"Percutaneous coronary intervention and atrial fibrillation: The triple therapy dilemma","volume":"39","author":"Cho","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"20","key":"10.3233\/CH-168104_ref6","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: The SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.3233\/CH-168104_ref7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation"},{"issue":"9872","key":"10.3233\/CH-168104_ref8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"issue":"13","key":"10.3233\/CH-168104_ref9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jacc.2009.10.058","article-title":"New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft","volume":"55","author":"El-Chami","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"23","key":"10.3233\/CH-168104_ref10","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.3233\/CH-168104_ref11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jacc.2013.03.041","article-title":"Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51","volume":"62","author":"Gibson","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10.3233\/CH-168104_ref12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: The randomized, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.3233\/CH-168104_ref13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/CH-141880","article-title":"Endothelial dysfunction after stenting and scaffolding of coronary arteries","volume":"58","author":"Gori","year":"2014","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"10.3233\/CH-168104_ref14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: The Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"issue":"23","key":"10.3233\/CH-168104_ref15","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"Hamm","year":"2011","journal-title":"European Heart Journal"},{"issue":"10","key":"10.3233\/CH-168104_ref16","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"issue":"9526","key":"10.3233\/CH-168104_ref17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"issue":"15","key":"10.3233\/CH-168104_ref18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"10","key":"10.3233\/CH-168104_ref19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: A nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"23","key":"10.3233\/CH-168104_ref20","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.3233\/CH-168104_ref21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/hrt.2007.134486","article-title":"Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation","volume":"94","author":"Lopes","year":"2008","journal-title":"Heart"},{"issue":"3","key":"10.3233\/CH-168104_ref22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/CH-141839","article-title":"Effect of specific surface microstructures on substrate endothelialisation and thrombogenicity: Importance for stent design","volume":"59","author":"Lutter","year":"2015","journal-title":"Clin Hemorheol Microcirc"},{"issue":"9281","key":"10.3233\/CH-168104_ref23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.3233\/CH-168104_ref24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/europace\/euu008","article-title":"Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: Results of the European Heart Rhythm Association Survey","volume":"16","author":"Potpara","year":"2014","journal-title":"Europace"},{"issue":"9","key":"10.3233\/CH-168104_ref25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jacc.2016.05.085","article-title":"Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"68","author":"Sutton","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.3233\/CH-168104_ref26","unstructured":"Task Force M. , Kirchhof P. , Benussi S. , Kotecha D. , Ahlsson A. , Atar D. , et al., ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO), Eur J Cardiothorac Surg (2016) pii: ehw210. [Epub ahead of print]."},{"issue":"9327","key":"10.3233\/CH-168104_ref27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 Research G, Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): A randomised controlled trial","volume":"360","author":"van Es","year":"2002","journal-title":"Lancet"},{"issue":"20","key":"10.3233\/CH-168104_ref28","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"The New England Journal of Medicine"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CH-168104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:06:01Z","timestamp":1777388761000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CH-168104"}},"subtitle":[],"editor":[{"given":"F.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"T.","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,21]]},"references-count":28,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/ch-168104","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,21]]}}}